Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters
iRADIOLOGY · 2026-10 · 4 (5) · 385-392
DOI: 10.1002/ird3.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift iRADIOLOGY, online erschienen am 21.09.2026. Verfasst von Xiaoxue Tian und 8 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Outcomes of radioactive iodine therapy in pediatric Graves' disease vary. This study aimed to evaluate the efficacy of radioactive iodine therapy and identify prognostic factors.
Methods
We retrospectively analyzed 156 pediatric patients with Graves' disease treated with radioactive iodine therapy between 2012 and 2022 with ≥ 1 year of follow‐up. Multivariate least absolute shrinkage and selection operator regression identified efficacy predictors. Outcomes were compared by planned activities (≥ 0.15 mCi/g vs. < 0.15 mCi/g) and thyrotrophin receptor antibody concentrations.
Results
Success rates rose from 60.1% (86/143) (3 months) to 79.3% (73/92) (12 months), and hypothyroidism increased from 39.9% (57/143) to 54.3% (50/92). Free triiodothyronine and thyroid‐stimulating hormone concentrations were identified as key predictors of efficacy. A higher treatment success rate was observed with planned activity ≥ 0.15 mCi/g (76.2% vs. 49.4%), although the difference was not statistically significant after Bonferroni correction (adjusted p = 0.056). Higher thyrotrophin receptor antibody concentrations showed a nonsignificant trend toward lower success of therapy.
Conclusions
Radioactive iodine shows time‐dependent efficacy in pediatric Graves' disease. Free triiodothyronine, thyroid‐stimulating hormone, and planned radioactive iodine activity were associated with treatment outcomes in this cohort. Higher planned activities were associated with higher cure rates but also an increased risk of hypothyroidism. These exploratory findings require prospective external validation before being applied to individualized treatment planning.
Zitieren
APA
Tian, X., Zhang, D., Wang, Y., Cao, L., Jian, J., Liu, J., Liang, C., Wang, Y., & Chen, Y. (2026). Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters. iRADIOLOGY, 4(5), 385-392. https://doi.org/10.1002/ird3.70087
Vancouver
Tian X, Zhang D, Wang Y, Cao L, Jian J, Liu J, et al. Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters. iRADIOLOGY. 2026;4(5):385-392. doi:10.1002/ird3.70087
BibTeX
@article{Tian2026,
author = {Tian, Xiaoxue and Zhang, Dan and Wang, Yihui and Cao, Lujie and Jian, Junpu and Liu, Jiangyan and Liang, Changping and Wang, Yinzhong and Chen, Yonghui},
title = {Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters},
journal = {iRADIOLOGY},
year = {2026},
volume = {4},
number = {5},
pages = {385--392},
doi = {10.1002/ird3.70087}
}
EUVIMED